A new AI model predicts chemotherapy response in early-stage breast cancer with higher accuracy and faster turnaround. What clinicians and investors should know.
AI Predicts Chemotherapy Response in Early-Stage Breast Cancer with High Accuracy Read More »
How AI and deep learning are detecting disease earlier than traditional methods, improving outcomes and lowering costs, with a focus on lung nodule detection in CT scans.
AI Revolutionizes Early Disease Detection: Faster, Smarter Diagnostics Read More »
How AI is reshaping precision medicine — from genomics and diagnostics to drug discovery, privacy risks and practical steps for clinicians and investors.
AI and Precision Medicine: The Next Wave of Personalized Healthcare Read More »
How Insilico Medicine’s Pharma.AI fuses foundation models, AI agents, Generative Biologics, Chemistry42, PandaClaw and MMAI Gym to speed drug discovery.
How AI and machine learning are reshaping medical diagnostics, drug discovery, personalized care, and the regulatory and ethical landscape.
AI in Healthcare: Current Impact and What Comes Next Read More »
ChemT Biotechnology raised $4M to scale CelMo, an AI virtual cell that models CHO, T cells and more to speed, lower cost and raise yields in biologics production.
ChemT Biotechnology Secures $4M to Embed AI Intelligence in Biomanufacturing Read More »
MHRA finds UK public supports AI in healthcare if safety, effectiveness and ongoing oversight are guaranteed. What this means for regulators, clinicians and developers.
UK Public Backs AI in Healthcare, Calls for Strong Regulatory Oversight Read More »
How AI analysis of routine ECGs can reveal hidden structural heart disease, improve detection in emergency departments, and what the SAGE trial means for clinical adoption.
A concise look at how AI uses genomics, imaging and real-world data to deliver personalized treatments, plus short-term barriers and next steps for adoption.
How AI Is Making Precision Medicine Practical Today Read More »
Explore how pan-cancer AI, accelerated annotation, LLMs, and multi-modal models are transforming cancer diagnostics, prognosis, and treatment planning.
